Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells
Hemant Varma, Andrew J. Skildum, Susan E. Conrad · 2007
Read Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells by Hemant Varma, Andrew J. Skildum, Susan E. Conrad (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001256.txt.
Description
Hormone-dependent breast cancers need estrogen to grow, so antiestrogen drugs are a mainstay of treatment, yet resistance is a major cause of failure. Hemant Varma, Andrew Skildum, and Susan Conrad report a route to that resistance in a 2007 PLOS ONE article. Their focus is pRb, the retinoblastoma protein, a brake on the cell division cycle.
The authors show that functional ablation of pRb activates the cell-cycle enzyme Cdk2 and causes antiestrogen resistance in human breast cancer cells. Losing one brake lets cells keep dividing despite the drug. The mechanism suggests where resistant tumors might be attacked.
Catalog record
| CREATOR | Hemant Varma, Andrew J. Skildum, Susan E. Conrad |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001256